Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
80
WELL Quote, Financials, Valuation and Earnings
Last price:
$149.93
Seasonality move
:
3.3%
Day range:
$147.21 - $151.74
52-week range:
$87.87 - $158.55
Dividend yield:
1.73%
P/E ratio:
96.96x
P/S ratio:
11.72x
P/B ratio:
3.04x
Volume:
2.2M
Avg. volume:
2.9M
1-year change:
65.58%
Market cap:
$97B
Revenue:
$7.9B
EPS (TTM):
$1.56
Analysts' Opinion
-
Consensus RatingWelltower has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $161.63, Welltower has an estimated upside of 6.86% from its current price of $151.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $127.00 representing 16.04% downside risk from its current price of $151.26.
Fair Value
-
According to the consensus of 12 analysts, Welltower has 6.86% upside to fair value with a price target of $161.63 per share.
WELL vs. S&P 500
-
Over the past 5 trading days, Welltower has overperformed the S&P 500 by 2.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Welltower does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Welltower has grown year-over-year revenues for 14 quarters straight. In the most recent quarter Welltower reported revenues of $2.2B.
Earnings Growth
-
Welltower has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Welltower reported earnings per share of $0.19.
Enterprise value:
109.6B
EV / Invested capital:
2.28x
Price / LTM sales:
11.72x
EV / EBIT:
99.77x
EV / Revenue:
13.96x
PEG ratio (5yr expected):
0.67x
EV / Free cash flow:
49.86x
Price / Operating cash flow:
41.88x
Enterprise value / EBITDA:
39.45x
Gross Profit (TTM):
$3B
Return On Assets:
2.03%
Net Income Margin (TTM):
12.12%
Return On Equity:
3.21%
Return On Invested Capital:
2.13%
Operating Margin:
12.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.8B | $6.5B | $7.9B | $1.7B | $2.2B | |
| Gross Profit | $2.2B | $2.5B | $3B | $681.9M | $809.9M | |
| Operating Income | $746.2M | $940.5M | $1.1B | $254.3M | $281.1M | |
| EBITDA | $2B | $2.4B | $2.8B | $634.3M | $748.3M | |
| Diluted EPS | $0.32 | $0.64 | $1.56 | $0.15 | $0.19 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.4B | $2.6B | $3.1B | $5B | $7.2B | |
| Total Assets | $32.5B | $34.9B | $37.9B | $44B | $51B | |
| Current Liabilities | $622.8M | $1.3B | $1.2B | $1.1B | $1.4B | |
| Total Liabilities | $15.3B | $15.9B | $16.5B | $17.6B | $18.5B | |
| Total Equity | $17.2B | $19B | $21.4B | $26.4B | $32.6B | |
| Total Debt | $13.8B | $14.1B | $14.5B | $15.7B | $15.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.3B | $1.6B | $2.3B | $370.5M | $559.2M | |
| Cash From Investing | -$3.7B | -$5.7B | -$5.5B | -$3.1B | -$2.2B | |
| Cash From Financing | $2.8B | $5.4B | $4.9B | $2.1B | $1.6B | |
| Free Cash Flow | $1.3B | $1.6B | $2.2B | $356M | $545.1M | |
WELL
Sector
Market Cap
$97B
$1B
Price % of 52-Week High
95.4%
80.31%
Dividend Yield
1.73%
3.33%
Shareholder Yield
-7.15%
3.41%
1-Year Price Total Return
65.58%
-1.98%
Beta (5-Year)
1.203
0.886
Dividend yield:
1.73%
Annualized payout:
$2.56
Payout ratio:
162.37%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$148.87
200-day SMA
Buy
Level
$125.33
Bollinger Bands (100)
Buy
Level
127.7 - 145.1
Chaikin Money Flow
Buy
Level
534.5M
20-day SMA
Buy
Level
$150.50
Relative Strength Index (RSI14)
Buy
Level
58.35
ADX Line
Buy
Level
38.32
Williams %R
Neutral
Level
-48.6974
50-day SMA
Buy
Level
$140.11
MACD (12, 26)
Buy
Level
2.03
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
463.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7378)
Buy
CA Score
(Annual)
Level (0.1782)
Buy
Beneish M-Score
(Annual)
Level (-2.4158)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-2.5183)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Welltower owns a diversified healthcare portfolio of 2,271 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
Stock Forecast FAQ
In the current month, WELL has received 9 Buy ratings 3 Hold ratings, and 0 Sell ratings. The WELL average analyst price target in the past 3 months is $161.63.
-
Where Will Welltower Stock Be In 1 Year?
According to analysts, the consensus estimate is that Welltower share price will rise to $161.63 per share over the next 12 months.
-
What Do Analysts Say About Welltower?
Analysts are divided on their view about Welltower share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Welltower is a Sell and believe this share price will drop from its current level to $127.00.
-
What Is Welltower's Price Target?
The price target for Welltower over the next 1-year time period is forecast to be $161.63 according to 12 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is WELL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Welltower is a Buy. 9 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of WELL?
You can purchase shares of Welltower via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Welltower shares.
-
What Is The Welltower Share Price Today?
Welltower was last trading at $149.93 per share. This represents the most recent stock quote for Welltower. Yesterday, Welltower closed at $151.26 per share.
-
How To Buy Welltower Stock Online?
In order to purchase Welltower stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
